Peer-influenced content. Sources you trust. No registration required. This is HCN.

Hematology AdvisorAlgorithmic Approach to Identify Patients With Germline Predisposition Syndromes (GPS), Including Those With Hematologic Malignancies

Review Publication: Hematology Advisor
At the Annual Meeting of the Society of Hematologic Oncology, researchers presented a study identifying a higher percentage of patients with germline predisposition syndromes (GPS).
Results: Following a review of medical records of patients diagnosed with GPS between 1994 and 2018, the investigators reported that the detection of GPS positively impacted medical care in 91% of cases, including proper selection of a bone marrow donor, selection of drug and conditioning regimens, and genetic counseling.